NCT07237334

Brief Summary

This study will characterise the patients using the Geriatric Emergency Medicine Unit, a unit which provides specialist care for patients aged 75 years and older attending the emergency department. It will examine how this specialist care impacts their health in terms of a number of different outcomes, such as; function, quality of life and health care usage; for example admission to the acute hospital.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 19, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2026

Completed
Last Updated

November 19, 2025

Status Verified

November 1, 2025

Enrollment Period

1.1 years

First QC Date

November 14, 2025

Last Update Submit

November 14, 2025

Conditions

Keywords

Comprehensive Geriatric Assessment

Outcome Measures

Primary Outcomes (1)

  • Our primary outcome is incidence of hospital admission at index GEM-U presentation

    Patients who attend GEM-U and have an acute hospital admission at this time

    Patients are followed at 30 days and 6 months

Secondary Outcomes (5)

  • Mortality

    Patients are followed at 30 days and 6 months

  • Unscheduled ED revisit

    Patients are followed at 30 days and 6 months

  • Unscheduled hospital visit(s)

    Patients are followed at 30 days and 6 months

  • Nursing home admission

    Patients are followed at 30 days and 6 months

  • Healthcare utilization (GP visit, out-patient geriatric services, PHN visit, HSCP services)

    Patients are followed at 30 days and 6 months

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

All prospective older adults attending the GEMU that meet inclusion criteria will be invited to participate. However, this will be limited to the working hours of the research team (Monday-Friday, 8:00-20:00).

You may qualify if:

  • Older adults aged ≥75 years
  • Manchester Triage System category 2-5
  • Screen positive for risk of adverse outcomes after ED visit (≥ 2 on ISAR screening tool)
  • Presenting with a medical condition
  • Reviewed by the Older Persons Integrated Care Team

You may not qualify if:

  • Patients presenting with a non-medical issue including major trauma or hip fracture
  • Patients presenting with acute stroke or transient ischaemic attack
  • Patients more appropriate to another alternative pathway e.g. deep vein thrombosis pathway, low risk chest pain pathway
  • Patients with acute coronary syndrome or unstable arrthymia
  • Patients requiring care in the resuscitation room
  • Patients with head injury (unless appropriate assessment and management has been fully completed by ED team)
  • Patients with possible spinal injury (unless appropriate assessment and management has been fully completed by ED/orthopaedic team)
  • Patients with low Glasgow Coma Scale

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Limerick

Limerick, Munster, V94 F858, Ireland

RECRUITING

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ida Carroll

    University of Limerick

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ida M Carroll, MSc

CONTACT

Rose Galvin

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2025

First Posted

November 19, 2025

Study Start

February 10, 2025

Primary Completion

March 30, 2026

Study Completion

March 30, 2026

Last Updated

November 19, 2025

Record last verified: 2025-11

Locations